Blockchain Registration Transaction Record

Scinai Immunotherapeutics Reports Q1 2025 Financial Results

Scinai Immunotherapeutics (SCNI) reports Q1 2025 financial results with revenue growth and decreased net loss. Learn more about the biopharmaceutical company's performance and innovative pipeline.

Scinai Immunotherapeutics Reports Q1 2025 Financial Results

This news matters as it highlights Scinai Immunotherapeutics' financial performance, showing revenue growth and reduced losses. Investors and stakeholders in the biopharmaceutical industry may find the company's expanding CDMO business and innovative pipeline of biological products of interest.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x6256691d99848e596cdec5c9ce0cfaf1a5d5774f8740fb2a4d2b72f69773ec5f
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintricei1wA-d09e6617eaf4d82853689bc194f86857